KMF Investments Recapitalizes Lineus Medical
June 1, 2026
Lineus Medical, developer of the SafeBreak Vascular breakaway IV device, completed a strategic recapitalization with KMF Investments. The transaction, finalized at the start of 2026, establishes KMF as a stable financial backer and provides resources to accelerate SafeBreak Vascular adoption and growth in the United States.
- Buyers
- KMF Investments
- Targets
- Lineus Medical
- Industry
- Medical Devices
- Location
- Arkansas, United States
- Transaction Type
- Recapitalization
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.